AAPM VL-Innovations in Adult and Pediatric Clinical Trials

2023 AAPM 65th Annual Meeting - Session: Innovations in Adult and Pediatric Clinical Trials

This video is currently visible only to AAPM Members, Affiliates and Developing Country Educational Associates. Embargo periods are typically one year from the date the presentation was first published.

AI in Structure Verification in Clinical Trials
Ying Xiao, PhD University of Pennsylvania

When you have finished the video, you may watch again, browse/search all videos, go back to the previous page, or watch another video in this session (see below). add this video to a playlist.

All videos in this session:

	Timing of Immunotherapy and Radiotherapy - Clemens Grassberger, PhD Massachusetts General Hospital
	Recent Findings from Adult Clinical Trials Impacting Radiotherapy - Leila Tchelebi Northwell Health
	Updates on Pediatric Clinical Trials Involving Radiotherapy - Koren Smith, MBA, MS UMass Chan Medical School

Graph includes 5 member loads and excludes non-members. Include? A load is defined as someone coming to this page, not necesarily that they pressed play, or watched the entire presentation.

AAPM is the American Association of Physicists in Medicine.
1631 Prince Street
Alexandria, VA 22314
Phone 571-298-1300
Fax 571-298-1301 
Send general questions to 2025.aapm@aapm.org

AAPM's Privacy Policy
Use of the site constitutes your acceptance to its terms and conditions.

AAPM is a scientific, educational, and professional nonprofit organization devoted to the discipline of physics in medicine. The information provided in this website is offered for the benefit of its members and the general public, however, AAPM does not independently verify or substantiate the information provided on other websites that may be linked to this site.

AAPM Virtual Library

2023 AAPM 65th Annual Meeting - Session: Innovations in Adult and Pediatric Clinical Trials

This video is currently visible only to AAPM Members, Affiliates and Developing Country Educational Associates. Embargo periods are typically one year from the date the presentation was first published.